Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J5FK
|
|||
Former ID |
DIB019922
|
|||
Drug Name |
GNE-7915
|
|||
Synonyms |
GNE7915; GNE 7915
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C19H21F4N5O3
|
|||
Canonical SMILES |
CCNC1=NC(=NC=C1C(F)(F)F)NC2=C(C=C(C(=C2)F)C(=O)N3CCOCC3)OC
|
|||
InChI |
1S/C19H21F4N5O3/c1-3-24-16-12(19(21,22)23)10-25-18(27-16)26-14-9-13(20)11(8-15(14)30-2)17(29)28-4-6-31-7-5-28/h8-10H,3-7H2,1-2H3,(H2,24,25,26,27)
|
|||
InChIKey |
XCFLWTZSJYBCPF-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dual specificity protein kinase TTK (MPS1) | Target Info | Inhibitor | [2] |
Leucine-rich repeat kinase 2 (LRRK2) | Target Info | Inhibitor | [2] | |
KEGG Pathway | Cell cycle | |||
NetPath Pathway | IL2 Signaling Pathway | |||
WikiPathways | Retinoblastoma (RB) in Cancer |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem. 2012 Nov 26;55(22):9416-33. | |||
REF 2 | Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem. 2014 Feb 13;57(3):921-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.